<?xml version="1.0"?>
<law>
  <structure>
    <unit label="article" identifier="gin" order_by="" level="1">Insurance</unit>
  </structure>
  <section_number>gin-15-841</section_number>
  <catch_line>...</catch_line>
  <order_by>841</order_by>
  <text>
    <section prefix="(a)">
      <section prefix="(1)">In this section the following words have the meanings indicated.</section>
      <section prefix="(2)">"Authorized prescriber" has the meaning stated in &#xA7; 12-101 of the Health Occupations Article.</section>
      <section prefix="(3)">
        <section prefix="(i)">"Nicotine replacement therapy" means a product that:<section prefix="1.">is used to deliver nicotine to an individual attempting to cease the use of tobacco products; and</section><section prefix="2.">is obtained under a prescription written by an authorized prescriber.</section></section>
        <section prefix="(ii)">"Nicotine replacement therapy" does not include any over-the-counter product that may be obtained without a prescription.</section>
      </section>
      <section prefix="(4)">"Tobacco product" has the meaning stated in &#xA7; 10-101 of the Criminal Law Article.</section>
    </section>
    <section prefix="(b)">
      <section prefix="(1)">This subsection applies to:<section prefix="(i)">insurers and nonprofit health service plans that provide coverage for prescription drugs to individuals or groups under health insurance policies or contracts that are issued or delivered in the State; and</section><section prefix="(ii)">health maintenance organizations that provide coverage for prescription drugs to individuals or groups under contracts that are issued or delivered in the State.</section></section>
      <section prefix="(2)">An entity subject to this subsection shall provide coverage for:<section prefix="(i)">except for a drug that may be obtained over-the-counter without a prescription, any drug that:<section prefix="1.">is approved by the United States Food and Drug Administration as an aid for the cessation of the use of tobacco products; and</section><section prefix="2.">is obtained under a prescription written by an authorized prescriber; and</section></section><section prefix="(ii)">two 90-day courses of nicotine replacement therapy during each policy year.</section></section>
      <section prefix="(3)">An entity subject to this subsection may not impose a different copayment or coinsurance requirement for a drug or nicotine replacement therapy provided under paragraph (2) of this subsection than is imposed for any other comparable prescription.</section>
    </section>
  </text>
</law>
